Join Andrew Frankel, a seasoned nephrologist, and Richard Lipscomb from Proteomics International, as they explore the groundbreaking potential of proteomics in predicting future diseases. Kirsten Peters reveals how blood protein biomarkers can anticipate conditions like kidney disease, esophageal cancer, and endometriosis years ahead of traditional methods. Smita Sinna discusses patient engagement and the economics of early testing. Together, they highlight a paradigm shift in healthcare from reactive treatment to proactive prevention, emphasizing the transformative possibilities of molecular science.
